Danimer Scientific Past Earnings Performance
Past criteria checks 0/6
Danimer Scientific's earnings have been declining at an average annual rate of -54.3%, while the Chemicals industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 9.1% per year.
Key information
-54.3%
Earnings growth rate
-36.4%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 9.1% |
| Return on equity | -55.9% |
| Net Margin | -333.0% |
| Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
Broker Revenue Forecasts For Danimer Scientific, Inc. (NYSE:DNMR) Are Surging Higher
Apr 25
Danimer Scientific Is In Trouble
Nov 17Danimer Scientific: It's Not Time To Buy
Sep 05Danimer Scientific: Falling Revenues, Negative Gross Margins, And The Biodegradable Plastics Dream
Jun 20Analyst Forecasts Just Became More Bearish On Danimer Scientific, Inc. (NYSE:DNMR)
May 15Danimer Scientific: Falling Momentum As Cash Burn Climbs
Dec 19What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates
Nov 17Danimer Scientific: Biodegradable Plastics Are Still Important
Sep 30Danimer Scientific stock slides on $100M securities offering
Aug 26These Analysts Think Danimer Scientific, Inc.'s (NYSE:DNMR) Sales Are Under Threat
Aug 17Danimer Scientific: Bright Future But Currently A Murky Investment Case
Jun 07Danimer Scientific: An Innovative Bioplastics Player With Huge Upside Potential
Mar 10Danimer Scientific: Growth Opportunities Will Promote Its Stock Price
Dec 24What Does The Future Hold For Danimer Scientific, Inc. (NYSE:DNMR)? These Analysts Have Been Cutting Their Estimates
Nov 25Danimer Scientific: Prepare For Takeoff
Aug 19Danimer Scientific Momentarily Stumbles In Mission To Produce Biodegradable Plastics
Jun 04Revenue & Expenses BreakdownBeta
How Danimer Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 47 | -155 | 73 | 28 |
| 30 Sep 23 | 51 | -144 | 75 | 28 |
| 30 Jun 23 | 51 | -199 | 77 | 30 |
| 31 Mar 23 | 50 | -190 | 81 | 31 |
| 31 Dec 22 | 53 | -180 | 85 | 31 |
| 30 Sep 22 | 56 | -164 | 89 | 33 |
| 30 Jun 22 | 59 | -61 | 97 | 29 |
| 31 Mar 22 | 60 | 8 | 94 | 25 |
| 31 Dec 21 | 59 | -60 | 82 | 20 |
| 30 Sep 21 | 53 | -51 | 64 | 14 |
| 30 Jun 21 | 53 | -61 | 41 | 10 |
| 31 Mar 21 | 50 | -102 | 24 | 9 |
| 31 Dec 20 | 47 | -9 | 17 | 7 |
| 30 Sep 20 | 44 | -9 | 15 | 7 |
| 30 Jun 20 | 40 | -3 | 14 | 6 |
| 31 Mar 20 | 35 | -11 | 15 | 5 |
| 31 Dec 19 | 32 | -20 | 17 | 5 |
| 31 Dec 18 | 30 | 0 | 7 | 5 |
Quality Earnings: DNMR is currently unprofitable.
Growing Profit Margin: DNMR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DNMR is unprofitable, and losses have increased over the past 5 years at a rate of 54.3% per year.
Accelerating Growth: Unable to compare DNMR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DNMR is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-16.2%).
Return on Equity
High ROE: DNMR has a negative Return on Equity (-55.92%), as it is currently unprofitable.